Leerink Partnrs Predicts Editas Medicine Q3 Earnings
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for Editas Medicine in a report released on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar forecasts that the company will post earnings of ($0.14) per share for the quarter. The consensus estimate […]
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for Editas Medicine in a report released on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar forecasts that the company will post earnings of ($0.14) per share for the quarter. The consensus estimate […]